Holdings (Monthly)
Guide ↗
Goldman Sachs Future Health Care Equity ETF
· Goldman Sachs ETF Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | LLY | Feb 2026 | 2,619 | +136 | $2.8M | +3.2% | 12.19% | EC |
| 2 | Johnson & Johnson | JNJ | Feb 2026 | 7,357 | +755 | $1.8M | +33.8% | 8.09% | EC |
| 3 | AstraZeneca PLC | AZN | Feb 2026 | 6,923 | -13 | $1.4M | +323.4% | 6.40% | EC |
| 4 | Merck & Co., Inc | MRK | — | 10,915 | NEW | $1.4M | — | 5.98% | EC |
| 5 | Boston Scientific Corporation | BSX | Feb 2026 | 17,062 | +1,742 | $1.3M | -15.7% | 5.80% | EC |
| 6 | Thermo Fisher Scientific Inc | TMO | Feb 2026 | 2,001 | -87 | $1.0M | -15.5% | 4.61% | EC |
| 7 | Intuitive Surgical Inc. | ISRG | Feb 2026 | 2,003 | +104 | $1.0M | -7.4% | 4.46% | EC |
| 8 | Guardant Health Inc | GH | Feb 2026 | 8,978 | +1,725 | $843K | +7.2% | 3.73% | EC |
| 9 | HOYA Corp. | 7741 | Feb 2026 | 4,523 | NEW | $819K | — | 3.62% | EC |
| 10 | Argenx SE | ARGX | Feb 2026 | 1,061 | +47 | $814K | -12.0% | 3.60% | EC |
| 11 | Cencora Inc | COR | Feb 2026 | 2,056 | +106 | $765K | +6.4% | 3.38% | EC |
| 12 | Abbott Laboratories | ABT | Feb 2026 | 6,078 | -1,917 | $707K | -31.4% | 3.13% | EC |
| 13 | Lonza Group AG | LONN | Feb 2026 | 953 | NEW | $664K | — | 2.94% | EC |
| 14 | Agilent Technologies Inc. | A | Feb 2026 | 5,409 | +299 | $657K | -16.3% | 2.90% | EC |
| 15 | DexCom Inc | DXCM | Feb 2026 | 8,247 | +3,453 | $606K | +99.0% | 2.68% | EC |
| 16 | Roivant Sciences Ltd | ROIV | Feb 2026 | 17,375 | NEW | $503K | — | 2.22% | EC |
| 17 | Mettler-Toledo International Inc | MTD | Feb 2026 | 293 | +10 | $400K | -4.2% | 1.77% | EC |
| 18 | Apogee Therapeutics Inc. | APGE | Feb 2026 | 5,225 | +1,443 | $366K | +34.4% | 1.62% | EC |
| 19 | Sartorius Stedim Biotech SA | DIM | Feb 2026 | 1,658 | NEW | $358K | — | 1.59% | EC |
| 20 | Ionis Pharmaceuticals, Inc. | IONS | — | 3,918 | NEW | $318K | — | 1.41% | EC |
| 21 | QIAGEN NV | QGEN | Feb 2026 | 6,309 | NEW | $314K | — | 1.39% | EC |
| 22 | Repligen Corporation | RGEN | — | 2,204 | NEW | $284K | — | 1.26% | EC |
| 23 | Insmed Inc | INSM | Feb 2026 | 1,846 | +79 | $276K | -24.9% | 1.22% | EC |
| 24 | Penumbra Inc. | PEN | — | 750 | NEW | $258K | — | 1.14% | EC |
| 25 | Goldman Sachs Trust | FTOXX | Feb 2026 | 245,420 | +32,403 | $245K | +15.2% | 1.09% | STIV |
| 26 | NATERA INC | NTRA | Feb 2026 | 1,137 | +33 | $237K | -10.3% | 1.05% | EC |
| 27 | Xenon Pharmaceuticals Inc | XENE | Feb 2026 | 5,393 | +167 | $233K | -0.2% | 1.03% | EC |
| 28 | Royalty Pharma PLC | RPRX | Feb 2026 | 4,939 | NEW | $228K | — | 1.01% | EC |
| 29 | UnitedHealth Group Inc. | UNH | Feb 2026 | 775 | +23 | $227K | -8.3% | 1.01% | EC |
| 30 | Cytokinetics Inc | CYTK | Feb 2026 | 3,546 | +264 | $221K | -1.3% | 0.98% | EC |
| 31 | Bridgebio Pharma Inc | BBIO | — | 3,115 | NEW | $207K | — | 0.92% | EC |
| 32 | Madrigal Pharmaceuticals Inc | MDGL | Feb 2026 | 466 | -198 | $201K | -49.2% | 0.89% | EC |
| 33 | Rhythm Pharmaceuticals Inc | RYTM | Feb 2026 | 2,150 | +1,202 | $199K | +92.8% | 0.88% | EC |
| 34 | CG Oncology Inc. | CGON | Feb 2026 | 3,187 | +553 | $187K | +58.7% | 0.83% | EC |
| 35 | Arcellx Inc | ACLX | Feb 2026 | 1,623 | +122 | $185K | +69.2% | 0.82% | EC |
| 36 | GeneDx Holdings Corp | WGS | Feb 2026 | 1,664 | +124 | $133K | -48.4% | 0.59% | EC |
| 37 | Revolution Medicines Inc | RVMD | Feb 2026 | 1,159 | -1,346 | $118K | -39.3% | 0.52% | EC |
| 38 | Insulet Corporation | PODD | Feb 2026 | 432 | -2,161 | $107K | -87.4% | 0.47% | EC |
| 39 | Ultragenyx Pharmaceuticals Inc | RARE | Feb 2026 | 3,619 | +272 | $85K | -27.2% | 0.37% | EC |
| 40 | Structure Therapeutics Inc | GPCR | — | 1,092 | NEW | $69K | — | 0.30% | EC |
| ✕ | Neurocrine Biosciences Inc | 64125C109 | — | 3,468 | SOLD | $0.5M | — | — | — |
| ✕ | Veeva Systems Inc | 922475108 | — | 1,793 | SOLD | $0.4M | — | — | — |
| ✕ | Danaher Corp | 235851102 | — | 1,673 | SOLD | $0.4M | — | — | — |
| ✕ | Alnylam Pharmaceuticals Inc | 02043Q107 | — | 481 | SOLD | $0.2M | — | — | — |
| ✕ | iRhythm Technologies Inc | 450056106 | — | 883 | SOLD | $0.2M | — | — | — |
| ✕ | West Pharmaceutical Services I | 955306105 | — | 555 | SOLD | $0.2M | — | — | — |